Israel represents one of the world's most dynamic landscapes for biotechnology and pharmaceutical research. As a global hub for innovation, Israeli pharmaceutical companies and research institutions require raw materials that strictly adhere to international quality standards such as GMP, ISO, and USP/EP grades. Cholic acid and its derivatives—specifically Ursodeoxycholic Acid (UDCA), Chenodeoxycholic Acid (CDCA), and Deoxycholic Acid—are critical precursors in the synthesis of drugs treating hepatobiliary disorders, metabolic diseases, and cholesterol-related pathologies.
Our company bridges the gap between high-scale manufacturing and the precision-oriented demands of the Israeli market. We recognize that in the Israeli life science sector, "Quality" is not merely a checkbox; it is the fundamental currency of trust. By integrating advanced biotechnical purification processes, we provide a reliable supply chain that ensures batch-to-batch consistency—a non-negotiable requirement for clinical-grade manufacturing and R&D formulation.
The pharmaceutical industry in Israel is pivoting toward "Green Chemistry" and sustainable API (Active Pharmaceutical Ingredient) sourcing. Our manufacturing facility has invested heavily in biocatalytic pathways to produce cholic acid series products. This technological leap reduces the usage of toxic organic solvents, aligning with the EU and Israeli environmental regulatory frameworks.
Looking ahead, we are expanding our R&D capacity to support the synthesis of high-value bile acid salts specifically customized for novel drug delivery systems (DDS) being pioneered in Israeli laboratories. We are not just a supplier; we are a partner in the clinical journey, providing documentation support (DMF, ASMF) to accelerate local regulatory approval processes.
Yes, we provide a full dossier of documentation including COA (Certificate of Analysis), MSDS, and GMP compliance certificates to facilitate smooth customs clearance and regulatory registration within Israel.
We absolutely do. We understand that early-stage drug development requires small, high-purity quantities. We offer flexible MOQ (Minimum Order Quantity) options tailored for R&D labs and pilot projects.
We maintain a strategic stock of core cholic acid derivatives. Standard orders are typically dispatched within 7-14 days. For large-scale industrial orders, our factory schedules production to optimize lead times and logistics costs.
Our production facilities are ISO9001 and ISO22000 certified. We strictly follow the principles of Good Manufacturing Practice (GMP) to ensure the safety and efficacy of all pharmaceutical raw materials.
Chenlv Herb
